TokenPost·
TScan Therapeutics Q3 Revenue Falls 76.7% to $586,000

The company recorded a GAAP loss of $0.25 per share for the quarter.
Every crypto headline. One feed. Updated every minute.

The company recorded a GAAP loss of $0.25 per share for the quarter.